TERNS PHARMACEUTICALS INC COM is a security (CUSIP 880881107) tracked across SEC portfolio filings. 255 institutional managers reported $6.7B on Form 13F as of 2026-06-30; 26 registered fund positions totaling $231.5M via N-PORT as of 2026-04-30.
Showing 15 of 255 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| BlackRock, Inc. | New York, NY | $504.5M | 9,569,585 |
| MORGAN STANLEY | NEW YORK, NY | $340.0M | 6,449,140 |
| Avoro Capital Advisors LLC | New York, NY | $300.2M | 5,695,000 |
| VANGUARD GROUP INC | Valley Forge, PA | $223.2M | 5,523,948 |
| Holocene Advisors, LP | New York, NY | $217.0M | 4,115,828 |
| Balyasny Asset Management L.P. | Chicago, IL | $204.9M | 2,779,445 |
| CITADEL ADVISORS LLC | MIAMI, FL | $197.6M | 3,218,810 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $178.9M | 3,011,558 |
| HBK INVESTMENTS L P | DALLAS, TX | $155.5M | 2,950,000 |
| JPMORGAN CHASE & CO | NEW YORK, NY | $151.8M | 2,869,728 |
| Ikarian Capital, LLC | DALLAS, TX | $140.0M | 1,456,378 |
| FRANKLIN RESOURCES INC | San Mateo, CA | $127.0M | 2,409,019 |
| Capitolis Liquid Global Markets LLC | NEW YORK, NY | $123.0M | 3,045,200 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $122.2M | 2,316,544 |
| Paradigm Biocapital Advisors LP | NEW YORK, NY | $116.9M | 2,216,499 |
Showing 15 of 26 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| SMALLCAP World Fund Inc | SMALLCAP World Fund Inc | $75.1M | 9.27% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $50.6M | 6.20% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $29.4M | 26.96% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $11.6M | 15.49% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $11.2M | 8.80% |
| Fidelity SAI Merger Arbitrage Fund | Fidelity Greenwood Street Trust | $9.3M | 162.18% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $8.2M | 17.02% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $8.2M | 80.92% |
| NYLI Merger Arbitrage ETF | New York Life Investments ETF Trust | $4.3M | 174.07% |
| The Gabelli ABC Fund | Gabelli Investor Funds Inc | $4.2M | 101.35% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $3.1M | 0.52% |
| Small Cap Core Portfolio | Bernstein Fund Inc | $3.0M | 41.33% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $2.7M | 0.88% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $1.8M | 27.03% |
| BlackRock Health Sciences Trust | BlackRock Health Sciences Trust | $1.7M | 31.97% |